Bridgeway Capital Management, LLC Pacific Biosciences Of California, Inc. Transaction History

Bridgeway Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $649,472 - $1.45 Million	-275,200 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $138,000 - $167,100	-30,000 Reduced 9.83%	275,200 $1.42 Million
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $259,350 - $508,300	-65,000 Reduced 17.56%	305,200 $2.26 Million
Q2 2018 Aug 14, 2018	BUY	$2.11 - $3.92 $411,872 - $765,184	195,200 Added 111.54%	370,200 $1.31 Million
Q1 2018 May 15, 2018	BUY	$2.05 - $3.23 $358,749 - $565,250	175,000 New	175,000 $359,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.